Cancer gene therapy
Cancer Gene Therapy covers gene and cell therapies for cancer, from CAR-T cells to oncolytic viruses and gene editing. Read by translational researchers and clinicians developing these treatments.
Overview
Cancer Gene Therapy, published by Springer Nature on nature.com, describes itself as the essential gene and cellular therapy resource for cancer researchers and clinicians. It publishes research articles, reviews and analysis, brief communications and news and comment on gene therapy, cellular therapy including CAR-T cells, cancer biology, drug discovery, genetics, immunology, molecular biology and biomarkers. It is a hybrid journal: subscription content with an open access option and open access funding guidance for authors. The journal began in 1994 and has appeared twelve times a year since 2000. Its editorial checks include cover letters on institutional letterhead and author contribution statements. Indexed in MEDLINE.